Adaptimmune Therapeutics plc (MUN:473A)
0.0125
0.00 (0.00%)
Last updated: May 21, 2026, 8:08 AM CEST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €7.58 million as of November 18, 2026. Its market cap has decreased by 5.89% in one year.
Market Cap
7.58M
Enterprise Value
-3.20M
Revenue
5.05M
Global Rank
n/a
Country Rank
n/a
PE Ratio
0.41
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 7.58M, a decrease of -99.30%. That is a compound annual growth rate of -34.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 7.58M | 29.13% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 65.09B |
| Bayer Aktiengesellschaft | 56.00B |
| Siemens Healthineers AG | 48.93B |
| Fresenius SE & Co. KGaA | 30.34B |
| FamiCord AG | 42.88M |
| MeVis Medical Solutions AG | 37.49M |
| aap Implantate AG | 18.78M |
| Maternus-Kliniken Aktiengesellschaft | 17.51M |